JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Internal Medicine Section DOI : 10.7860/JCDR/2020/46312.14176
Year : 2020 | Month : Nov | Volume : 14 | Issue : 11 Full Version Page : OC01 - OC04

BAP 65 and DECAF scores in Predicting Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Observational Study

Sashideep Reddy Telukutla1, TA Vidya2, SK Nellaiappa Ganesan3

1 Postgraduate, Department of General Medicine, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Potheri, Kattankulathur-603203, Chengalpattu District, Tamil Nadu, India.
2 Associate Professor, Department of General Medicine, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Potheri, Kattankulathur-603203, Chengalpattu District, Tamil Nadu, India.
3 Professor, Department of General Medicine, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Potheri, Kattankulathur-603203, Chengalpattu District, Tamil Nadu, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. TA Vidya, H129/2, 34th Cross Street, Besant Nagar, Chennai-600090, Tamil Nadu, India.
E-mail: tavidya@gmail.com
Abstract

Introduction

Chronic Obstructive Pulmonary Disease (COPD) is the fourth most common cause of mortality in the world. Acute Exacerbation of COPD (AECOPD) is a common entity to the emergency room of physician. It also contributes to the morbidity and mortality of the disease. Since multiple factors influence the outcomes of AECOPD, many prognostic indices incorporating various parameters have been proposed. BAP 65 {Blood Urea Nitrogen (BUN), Altered mental status, Pulse rate and age >65 years} and Dyspnoea grade, Eosinopenia, Consolidation, Acidemia and Atrial fibrillation (DECAF) are two which are commonly used. Head-to-head comparisons of these scores in their ability to correctly predict outcomes will aid the clinician in decision-making.

Aim

To evaluate the performance of BAP 65 and DECAF scores in accurately predicting need for mechanical ventilation and mortality in patients with AECOPD.

Materials and Methods

In this prospective observational study, 170 patients presenting with AECOPD to the emergency department were recruited condivutively. All patients were clinically examined and all variables for the calculation of the two scores were documented at baseline. Routine neurological examination was used to determine altered sensorium at admission. Following this, all patients underwent appropriate investigations including chest X-ray, Electrocardiogram (ECG) and arterial blood gas estimation. BAP 65 and DECAF scores were recorded and patients were followed till death or improvement. The results were analysed using Statistical Package for the Social Sciences (SPSS) software version 23. Student’s t-test, Mann-Whitney test and Chi-square test were used depending on the type of variables. Receiver Operating Characteristic (ROC) analysis was done and Area Under the Curve (AUC) was determined. A p-value <0.5 was deemed to be significant for all tests.

Results

Out of 170 patients, 48 required non-invasive ventilation and 30 required invasive ventilation and 23 (13.5%) expired. Mortality correlated significantly with age, median years of COPD, smoking pack years and hospitalisations in the past one year and also with lower haemoglobin and higher total leucocyte counts and BUN values. Both BAP 65 and DECAF scores correlated with need for mechanical ventilation and mortality. Area Under Receiver Operator Characteristic Curves (AUROC) predicting mortality was 0.712 for BAP 65 and 0.965 for DECAF scores. AUROC predicting need for ventilation was 0.583 for BAP 65 and 0.791 for DECAF scores. DECAF showed sensitivity of 78.26%, specificity of 95.92%, Positive Predictive Value (PPV) of 75%, Negative Predictive Value (NPV) of 96.58%, with an accuracy of 87.09% in predicting mortality. In predicting need for mechanical ventilation, DECAF had sensitivity of 32.14%, specificity of 94.74%, PPV of 75%, NPV of 73.97% with an accuracy of 63.44%. DECAF showed a higher positive predictive value for both outcomes.

Conclusion

History and basic clinical examination provide a lot of data to formulate prognosis in AECOPD. In resource-poor settings, BAP 65 can be used while DECAF can be used where arterial blood gas analysis is readily available, since both have proven to correlate with outcomes.

Keywords

Introduction

Chronic Obstructive Pulmonary Disease (COPD) is defined as a “clinically treatable disease distinguished by respiratory symptoms that are persistent, and is associated with a significant airflow limitation that is chronic and not completely reversible” [1]. It includes emphysema, chronic bronchitis and small airway disease. It is ranked fourth among the major causes of mortality on the global stage at present [2] and is expected to occupy the third position by 2020 [3]. In patients with moderate to severe COPD, exacerbation of symptoms has a devastating impact on the progression of disease as well as quality of life. Hence, a comprehensive approach including prevention, prompt diagnosis and immediate management of the exacerbation is required. According to The American Thoracic Society and European Respiratory Society, AECOPD is defined as an “acute change in the patient’s cough, sputum or dyspnoea that is beyond normal variability and that is sufficient to warrant a change in therapy” [4]. Multiple parameters appear to influence outcomes in AECOPD, such as length of hospital stay, need for mechanical ventilation and mortality. Due to this, the exact estimation of prognosis in such patients is difficult. In patients with stable form of COPD, there are well known scores such as BODE (Body mass index, airway Obstruction by FEV1, Dyspnoea by Modified Medical Research Council (MMRC) score, Exercise tolerance by 6 minute walking distance) index which have been rigorously scrutinised [5]. For episodes of acute exacerbation, many indices have been proposed to predict the outcomes. DECAF [6] score and BAP 65 [7] score are two of these prognostic indices. Parameters in BAP 65 score are BUN, altered mental status, pulse rate and age >65 years. Parameters in DECAF score are dyspnoea grade, eosinopenia, consolidation, acidemia and atrial fibrillation. For the physician in the emergency room, in a resource-poor country like India where there is a large volume of patients, it is necessary to have a set of guidelines regarding the requirement of mechanical ventilation and ICU admission so as to use the available sparse resources in a judicious manner. While the variables of DECAF score are obtained in a well-equipped emergency room setting, BAP 65 score is a relatively easy score to calculate in patients admitted with AECOPD. Hence, comparison of the two scores will aid in directing the physician towards logical use of resources, thereby decreasing deaths and significant morbidity.

We therefore aimed to compare the performance of BAP 65 and DECAF scores in accurately predicting need for mechanical ventilation and mortality in patients with AECOPD.

Materials and Methods

This prospective, observational study was conducted from February 2018 to September 2019 in a university hospital situated in a semi-urban area after obtaining Institutional Ethics Committee clearance (1337/IEC/2018). Sample size was calculated assuming the proportion of people with “COPD” to be 37% as per the study by Gupta D et al., using the formula N=4 PQ/L2 [8].

Patients of either sex diagnosed with AECOPD in General Medicine and Pulmonology Out Patient Department (OPD) and Emergency Room (ER) and older than 40 years were included in the study at the time of admission to the hospital using convenience sampling. Subjects who were already on domiciliary ventilation support, less than 40 years of age and unwilling to give consent were excluded from the study. All the eligible subjects were recruited into the study consecutively until the required sample size was obtained.

After obtaining informed consent, patient demographics and history was recorded and a complete physical examination was performed. Score of <14 on Glasgow Coma Scale (GCS) or physician assessment as disoriented, drowsy was taken to indicate altered mental status [9]. All routine investigations were performed. BUN, total and differential White Blood Cell (WBC) count. ECG, Chest X-ray, arterial blood gas analysis were done on all patients. Blood urea >43 mg% and BUN >20 mg% (as per hospital reference range) were taken as abnormal. The two scores were calculated with information obtained. Following this all patients were followed by a daily visit until discharge or death. The outcome of the patient was noted as either improved (Survivor) or death (Non- Survivor). The number of patients needing mechanical ventilation was also noted.

The two scores were then compared on the basis of the outcome, using statistical analysis.

Statistical Analysis

Statistical analysis was done using SPSS software version 23. If the variables were continuous, they were represented as “Mean±SD” and if the variables were of uneven distribution they were expressed as median. All the categorical variables were stated as frequencies and percentages. Continuous variables having a normal distribution with respect to the outcome were compared using “Student’s t-test”, while those having a non-normal distribution were compared by “Mann-Whitney U test”. Categorical data across the various groups was evaluated by “Chi-square test or Fisher’s-exact test”. ROC analysis was computed to decide on the actual cut-off value for DECAF score and BAP 65 score. The AUC, sensitivity and specificity were computed so as to compare the diagnostic efficacy of DECAF score and BAP 65 score. For all the tests, p<0.05 was deemed to be significant.

Results

170 patients were admitted with AECOPD were included in the study. Maximum numbers were in the age group of 61-70 years (37.1%) [Table/Fig-1]. A total of 108 (63.5%) were male and 62 (36.5%) were female.

Age distribution.

Age (years)FrequencyPercentage
40-505230.6
51-602212.9
61-706337.1
71-802313.5
>80105.9
Total170100.0

Of 170 patients, 23 (13.5%) patients died while 147 (86.5%) patients survived. A total of 48 patients required non-invasive ventilation and 30 required invasive ventilation and 23 expired. Among the total of 170 subjects with AECOPD, 86 were smokers and 42 had history of significant biomass exposure. Sputum culture sensitivity was positive in 76 (44.7%) patients and negative in 94 patients (55.3%).

Older age, longer duration of disease, increased smoking pack years and increased duration of hospital stay were associated significantly with death. Previous hospital admissions in the preceding year were also associated with bad outcome [Table/Fig-2].

Comparison of baseline characteristics of two groups.

VariablesSurvivors (n=147)Non-survivors (n=23)p-value*
Age (years)59.28±12.1169.1±12.90.002
Sex (Male/Female)90/5718/50.16
Duration of illness (Median) (years)9 (2-14)10 (8-18)0.04
Smoking pack years12.13±14.6731.87±17.88<0.0001
Duration of hospital stay (days)7.84±2.8711.9±5.090.001
No. of hospital admissions in past one year0.93±0.572.78±1.38<0.0001

(*Independent t-test. For gender, Chi-square test); p<0.05 was deemed to be significant.


Among basic laboratory investigations, haemoglobin value, Total Leucocyte Count (TLC) and BUN level at baseline were all significantly different between survivor and non-survivor groups [Table/Fig-3].

Comparison of laboratory parameters.

VariablesSurvivors (N=147)Non-survivors (n=23)p-value*
Haemoglobin (g/dL)12.04±1.3411.33±1.860.03
Total leucocyte count/mm310698.98±3724.7814935.09±4264.65<0.001
Blood urea nitrogen (mg/dL)21.49±11.0231.57±19.020.02

(*Independent t-test); p<0.05 was deemed to be significant.


For DECAF score, dyspnoea grade 5a and atrial fibrillation did not significantly differ between the two groups [Table/Fig-4].

DECAF score comparison.

VariableSurvivorsNon-survivorsp-value*
Dyspnoea grade 5a28 (19%)3 (13%)0.6
Dyspnoea grade 5b19 (12.9%)20 (87%)0.0005
Eosinopenia (<0.05×109/l)9 (6.1%)9 (39.1%)0.0005
Consolidation60 (40.8%)18 (78.3%)0.001
Acidemia (ph <7.3)27 (18.4%)20 (87%)0.0005
Atrial fibrillation11 (7.5%)4 (17.4%)0.125

(*chi-square test); p<0.05 was deemed to be significant.


All parameters of the BAP 65 score showed significant difference between survivor and non-survivor groups [Table/Fig-5].

BAP 65 score comparison.

VariableSurvivors (N=147)Non-survivors (N=23)p-value
Blood urea nitrogen >25 mg %36 (24.5%)14 (60.9%)0.0005
Altered mental status29 (19.7%)9 (39.1%)0.038
Pulse >109/min25 (17.0%)8 (34.8%)0.045
Age >65 years57 (38.8%)17 (73.9%)0.002

(chi-square test); p<0.05 was deemed to be significant.


The ROC curve shows that, for the outcome of mortality, both DECAF and BAP 65 scores were valid scores (AUC 0.965 and 0.712, respectively). But positive predictive value and sensitivity was more with DECAF. It showed a higher chance of prediction of mortality when compared to the BAP 65 score [Table/Fig-6a,b].

Comparison of scores with respect to mortality.

DECAF scoreBAP 65 score
Area under curve (95% Confidence interval)0.965 (0.936-0.993)0.712 (0.600-0.823)
Sensitivity (%)78.26%34.78%
Specificity (%)95.92%87.07%
Positive predictive value (%)75%29.63%
Negative predictive value (%)96.58%89.51%
p-value0.00050.001
Accuracy (%)87.09%60.93

ROC curve with respect to mortality.

ROC curves for both scores showed validity for both with respect to the need for mechanical ventilation. However, the BAP 65 score as a predictor for mechanical ventilation had an AUC of 0.583, which is just above the baseline required for a score to be valid while DECAF had AUC of 0.791 [Table/Fig-7a,b].

Comparison of scores with respect to need for mechanical ventilation.

DECAF scoreBAP 65 score
Area under curve (95% Confidence interval)0.791 (0.718-0.865)0.583 (0.494-0.671)
Sensitivity (%)32.14%16.07%
Specificity (%)94.74%84.21%
Positive predictive value (%)75%33.33%
Negative predictive value (%)73.97%67.13%
p-value0.00050.081
Accuracy (%)63.44%50.14%

ROC curve for mechanical ventilation.

Discussion

The study population comprised 170 patients admitted with AECOPD. The majority were males (n=108, 63.5%). 37.1% of patients were in the age group 61-70 years. Older age group is a known risk factor for AECOPD [10,11]. 23 (13.1%) patients succumbed. The mortality rate is lower when compared to a study done by Jayadev A et al., wherein the mortality rate was around 16.8% [12], but higher than those reported by Steer J et al., and Shorr AF et al., (10.4% and 4%, respectively) [6,7]. In the present study, 39.4% of the subjects required ICU care. Out of the 67 patients transferred to ICU, 23 patients died. A total of 78 patients required mechanical ventilation, while 30 (17.6%) required invasive ventilation. The frequency of people requiring invasive mechanical ventilation in this study was higher when compared to Mohan A et al., where 15.5% of the subjects required invasive mechanical ventilation [13]. Smoking burden increased the risk of death due to AECOPD [Table/Fig-2]. This is similar to a Korean study which found that in people aged more than 60 years who have been smoking for greater than 20 years, the risk of having severe COPD is high [14]. Another risk factor for death was higher rate of hospital admission in the year prior to current admission. A retrospective study of 900 patients in Spain found that previous severe exacerbations were associated with new AECOPD [15]. Also, Slenter R et al., showed in another retrospective study that one year mortality for hospitalised patients with AECOPD was 27.7% [16]. Significant difference in TLC between survivors and non-survivors points to the role of infection as an important prognostic factor in the estimation of mortality.

Predictors of Outcome

Many scores have been devised to predict outcomes in AECOPD. BAP 65 and DECAF are two such well-validated scores. Echevarria C et al., showed robust internal validity (AUC 0.83) and external validity (AUC 0.82) for the DECAF score in predicting mortality [17]. A study from Southern India found that BAP 65 score correlated well with mortality and need for mechanical ventilation with a sensitivity of 71.9% and specificity of 86.9% [18]. Two studies, one from Tamil Nadu and one from Karnataka looked at the ability of DECAF scores in predicting outcomes depending on the severity of the scoring, but did not compare it to other scores [19,20]. A study from Kerala, on the other hand, looked at independent predictors of mortality in AECOPD and concluded that anaemia could be a risk factor [21].

Sangwan V et al., conducted a pilot study with 50 patients comparing DECAF and BAP 65 scores [22]. They opined that both scores did well. Another Indian study from Kannur, Kerala compared multiple scoring systems (DECAF, BAP 65, CAPS, APACHE II and CURB-65) with 150 patients and concluded that a DECAF score ≥2 with an AUROC of 0.729 correlated best with mortality [23]. A retrospective Spanish study compared CURB 65, DECAF and BAP 65. Curb 65 had the highest sensitivity and NPV, while BAP 65 performed least well [24]. On the other hand, two studies from Egypt had different results. Yousif M et al., in a comparison of BAP 65, DECAF, modified DECAF and 2008 scores found that BAP 65 had the highest AUROC (0.861) to predict mortality [25]. Sweed RA et al., compared APACHE II, BAP 65, 2008 and CAPS scores and found that while all correlated significantly with mortality, APACHE II and 2008 scores best predicted need for mechanical ventilation. Furthermore, previous need for mechanical ventilation was the best predictor of need for mechanical ventilation in current admission [26]. Study done by Steer J et al., found that every variable of DECAF score was a self-determining, prognosticator of mortality [6]. In the current study, all variables except atrial fibrillation and Grade 5a dyspnoea were significantly correlated. On the other hand, all variables of BAP 65 were significantly higher in non-survivors than survivors.

In the current study, both DECAF and BAP 65 scores were valid for prediction of mortality (AUC 0.965 and 0.712, respectively) and need for mechanical ventilation. But DECAF had higher sensitivity and higher chance of prediction of mortality than the BAP 65 score. AUC for BAP 65 score as a predictor for mechanical ventilation was 0.583 which is just above the baseline required for a score to be valid whereas the AUC for DECAF score was found to be 0.791 making it a better predictor than BAP 65 score with respect to need of mechanical ventilation.

The sheer number of scoring systems available for AECOPD makes it difficult to choose one for regular clinical application. Many of the above studies have not only validated the DECAF score, but also has given stratifications for predicting mortality in this population. It is easily applicable in centres with medium to higher facilities and should probably be the score used to triage these patients. On the other hand, in resource-poor settings and rural areas, BAP 65 would still be the choice. The small number of studies available also demonstrates the need for well-planned multicentric studies to guide us, given the diversity and size of the Indian population.

The strength of this study lies in the number of patients recruited and the real-life setting in a large university hospital.

Limitation(s)

The following are the limitations of the study. Firstly, admission to ICU and decision to ventilate was physician-based and not protocol-based. Secondly, co-morbidities of the patients may have had a confounding effect on the final outcomes. Thirdly, stratification on basis of age (which is a risk factor) or individual scores was not done and lastly selection bias in the form of patients with mild exacerbation refusing to get admitted or refusal for admission due to other logistical reasons.

Conclusion(s)

In AECOPD, duration of illness, smoking and previous hospitalisations as well as infection trigger to the episode are correlated with poor mortality outcome. Both DECAF score and BAP 65 score are valid scores with respect to likelihood of need for mechanical ventilation and mortality outcome. DECAF score better predicts the need for mechanical ventilation in AECOPD.

(*Independent t-test. For gender, Chi-square test); p<0.05 was deemed to be significant.(*Independent t-test); p<0.05 was deemed to be significant.(*chi-square test); p<0.05 was deemed to be significant.(chi-square test); p<0.05 was deemed to be significant.

References

[1]Mirza S, Clay RD, Koslow MA, Scanlon PD, COPD guidelines: A review of the 2018 GOLD report Mayo Clinic Proceedings 2018 Elsevier10.1016/j.mayocp.2018.05.02630286833  [Google Scholar]  [CrossRef]  [PubMed]

[2]Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010 The Lancet 2012 380(9859):2095-128.10.1016/S0140-6736(12)61728-0  [Google Scholar]  [CrossRef]

[3]Mathers CD, Loncar D, Projections of global mortality and burden of disease from 2002 to 2030 PLoSMed 2006 3(11):e44210.1371/journal.pmed.003044217132052  [Google Scholar]  [CrossRef]  [PubMed]

[4]Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper Eur Respir J 2004 23(6):932-46.10.1183/09031936.04.0001430415219010  [Google Scholar]  [CrossRef]  [PubMed]

[5]Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 2004 350(10):1005-12.10.1056/NEJMoa02132214999112  [Google Scholar]  [CrossRef]  [PubMed]

[6]Steer J, Gibson J, Bourke SC, The DECAF Score: Predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease Thorax 2012 67(11):970-76.10.1136/thoraxjnl-2012-20210322895999  [Google Scholar]  [CrossRef]  [PubMed]

[7]Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP, Validation of a novel risk score for severity of illness in acute exacerbations of COPD Chest 2011 140(5):1177-83.10.1378/chest.10-303521527510  [Google Scholar]  [CrossRef]  [PubMed]

[8]Gupta D, Agarwal R, Aggarwal A, Maturu V, Dhooria S, Prasad K, Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations Lung India 2013 30(3):228-67.10.4103/0970-2113.11624824049265  [Google Scholar]  [CrossRef]  [PubMed]

[9]Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF, Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease development and validation of a simple risk score Arch Intern Med 2009 169(17):1595-602.10.1001/archinternmed.2009.27019786679  [Google Scholar]  [CrossRef]  [PubMed]

[10]Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study The Lancet 2007 370(9589):741-50.10.1016/S0140-6736(07)61377-4  [Google Scholar]  [CrossRef]

[11]Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, COPD in Japan: The Nippon COPD Epidemiology study Respirology 2004 9(4):458-65.10.1111/j.1440-1843.2004.00637.x15612956  [Google Scholar]  [CrossRef]  [PubMed]

[12]Jayadev A, Stone R, Steiner MC, McMillan V, Roberts CM, Time to NIV and mortality in AECOPD hospital admissions: An observational study into real world insights from National COPD Audits BMJ Open Respir Res 2019 6(1):e00044410.1136/bmjresp-2019-00044431423314  [Google Scholar]  [CrossRef]  [PubMed]

[13]Mohan A, Premanand R, Reddy LN, Rao MH, Sharma SK, Kamity R, Clinical presentation and predictors of outcome in patients with severe acute exacerbation of chronic obstructive pulmonary disease requiring admission to intensive care unit BMC Pulm Med 2006 6(1):2710.1186/1471-2466-6-2717177991  [Google Scholar]  [CrossRef]  [PubMed]

[14]Kim EJ, Yoon SJ, Kim YE, Go DS, Jung Y, Effects of aging and smoking duration on cigarette smoke-induced COPD Severity J Korean Med Sci 2018 34(Suppl 1):e90-e.10.3346/jkms.2019.34.e9030923493  [Google Scholar]  [CrossRef]  [PubMed]

[15]Santibáñez M, Garrastazu R, Ruiz-Nuñez M, Helguera JM, Arenal S, Bonnardeux C, Predictors of hospitalised exacerbations and mortality in chronic obstructive pulmonary disease PLoS ONE 2016 11(6):e015872710.1371/journal.pone.015872727362765  [Google Scholar]  [CrossRef]  [PubMed]

[16]Slenter R, Sprooten R, Kotz D, Wesseling G, Wouters E, Rohde G, Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease Respiration 2013 85(1):15-26.10.1159/00034203623037178  [Google Scholar]  [CrossRef]  [PubMed]

[17]Echevarria C, Steer J, Heslop-Marshall K, Stenton S, Hickey P, Hughes R, Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD Thorax 2016 71(2):133-40.10.1136/thoraxjnl-2015-20777526769015  [Google Scholar]  [CrossRef]  [PubMed]

[18]Kumaraguru KS, Ramakrishnan GA, Utility of BAP-65 score in assessing the severity and predicting the outcome in acute exacerbation of COPD, in a tertiary care hospital in South India Eur Respir J 2015 46:PA398110.1183/13993003.congress-2015.PA3981  [Google Scholar]  [CrossRef]

[19]Saranya S. The DECAF Score: Prognostication scoring system for patients hospitalised with acute exacerbation of chronic obstructive pulmonary disease. (2015). Corpus ID: 80912346. Semantic Scholar. Available at Repository-Tnmgrmu.Ac.in  [Google Scholar]

[20]Bansal AG, Gaude GS, Predictors of mortality in acute exacerbations of chronic obstructive pulmonary disease using the dyspnea, eosinopenia, consolidation, acidemia and atrial fibrillation score Lung India 2020 37:19-23.10.4103/lungindia.lungindia_114_1931898616  [Google Scholar]  [CrossRef]  [PubMed]

[21]Ittyachen AM, Krishnamoorthy S, Bhatt AN, Abdulla S, Roy JO, Sugathan M, Predictors of outcome in patients admitted with acute exacerbation of chronic obstructive pulmonary disease in a rural Tertiary Care Center J Family Med Prim Care 2016 5(2):411-15.10.4103/2249-4863.19236527843851  [Google Scholar]  [CrossRef]  [PubMed]

[22]Sangwan V, Chaudhry D, Malik R, Dyspnea, eosinopenia, consolidation, acidemia and atrial fibrillation score and BAP-65 score, tools for prediction of mortality in acute exacerbations of chronic obstructive pulmonary disease: A comparative pilot study IJCCM 2017 21(10):67110.4103/ijccm.IJCCM_148_1729142379  [Google Scholar]  [CrossRef]  [PubMed]

[23]Thambi N, Padmanabhan KV, Manoj DK, Rajani M, Comparison of scoring systems for mortality prediction in acute exacerbation of chronic obstructive pulmonary disease Journal of Medical Science and Clinical Research 2017 5(3):19125-132.10.18535/jmscr/v5i3.130  [Google Scholar]  [CrossRef]

[24]Parras AMV, Bautista CL, Chica GP, Lopez ML, Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort Eur Respir J 2017 50:PA931DOI: 10.1183/1393003.congress-2017.PA931  [Google Scholar]

[25]Yousif M, El Wahsh RA, Predicting in-hospital mortality in acute exacerbation of COPD: Is there a golden score? Egypt J Chest Dis Tuberc 2016 65(3):579-84.10.1016/j.ejcdt.2016.03.003  [Google Scholar]  [CrossRef]

[26]Sweed RA, Shaheen MM, El Gendy EA, Usefulness of different prognostic scores for AECOPD: APACHE II, BAP65, 2008, and CAPS scores The Egyptian Journal of Bronchology 2019 13(4):498-504.10.4103/ejb.ejb_20_19  [Google Scholar]  [CrossRef]